Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study
Publication date: September 2026 Source: International Journal of Cardiology Congenital Heart Disease, Volume 25 Author(s): Dennis D. Kumi, George Blankson, Irene Animah Acheampong, Samuel Michael Odoi, Sudhir Mungee, Timir Baman, Amit Mehrotra, Siddharth Shah
Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study. // International Journal of Cardiology Congenital Heart Disease. – URL: https://www.sciencedirect.com/science/article/pii/S2666668526000406?dgcid=rss_sd_all
Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study. International Journal of Cardiology Congenital Heart Disease. https://www.sciencedirect.com/science/article/pii/S2666668526000406?dgcid=rss_sd_all
“Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study.” International Journal of Cardiology Congenital Heart Disease.
@article{article49535,
title = {Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study},
journal = {International Journal of Cardiology Congenital Heart Disease},
url = {https://www.sciencedirect.com/science/article/pii/S2666668526000406?dgcid=rss_sd_all}
}